Electra amasses $350M in biotech’s latest big IPO
Nearly a dozen biotechnology firms have matched or raised more than $300 million in their initial public offerings in 2026, a figure not seen since new stock sales peaked in 2021, according to BioPharma Dive data.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
Also reported by 1 other outlet
- Electra's $350M IPO will help it become a commercial biotech endpoints.news